MagPlasma was granted U.S. Patent No. 12,109,523 for its system reducing airborne pathogens in personal breathing zones, expanding the company’s IP portfolio in air sterilization.
MagPlasma was granted U.S. Patent No. 12,109,523 for its system reducing airborne pathogens in personal breathing zones, expanding the company’s IP portfolio in air sterilization.